Chemists will provide girls as young as 13 with contraception without telling parents or GP
By Daily Mail Reporter
Last updated at 12:28 PM on 1st November 2010
A controversial scheme that lets girls as young as 13 obtain the contraceptive pill without their parents knowledge, has been launched.
Teenagers in the Isle of Wight (popn.140,000) who visit the chemist for the morning-after pill will also be able to pick up a month's supply of the contraceptive desogestrel without seeing a doctor or telling their parents.
After a month the girls would need to see a GP or sexual health nurse to get a further supply.
Ten of the 30 pharmacies on the island will be part of the pilot scheme.
The latest pregnancy figures from the Isle of Wight show that 96 girls under the age of 18 became pregnant in 2008.
The service will be aimed at females aged between 13 and 25 years old.
Read more: http://www.dailymail.co.uk/health/article-1325521/Chemists-provide-girls-young-13-long-term-contraception-telling-parents.html#ixzz142PxXEY9
25.10.10
CCHSE NOW CCHL
The Canadian College of Health Service Executives Celebrates Four Decades with
a New Name, the Canadian College of Health Leaders
(Halifax, NS – October 15, 2010) – The Canadian College of Health Service Executives announced its new name, the Canadian College of Health Leaders during its October 2010 Board of Directors meeting in Halifax. The new name is reflective of who the College is today and its future direction. The College’s commitment to health leaders throughout their career and to Canada’s health system is reflected in the accompanying tagline – Learning, Leading, Inspiring.
For four decades, the Canadian College of Health Leaders has brought together established and emerging health leaders from across Canada to learn, network, and exchange best practices—all with the aim of strengthening Canada’s health system. The College is confident as it enters its next four decades that it is on track to build on, strengthen and renew its services, the new name speaks to the value and benefits of the organization.
“In our consultation with College members as well as potential members it became evident that many did not see themselves reflected in the old name, specifically in the term ‘health service executives’, either because their work was not properly in the health services domain or because they were not in what they perceived as an executive role. The new College name allows us to address this while preparing the College to better recognize the importance of developing leaders early in their career” said College President Ray Racette, MHA, CHE.
“Our new name clearly emphasizes our focus on leadership and learning and our alignment with the recently established LEADS in a Caring Environment leadership capabilities framework. It reflects our commitment to support leadership development across the continuum of a career” commented Board Chair John King, MHA, CHE.
a New Name, the Canadian College of Health Leaders
(Halifax, NS – October 15, 2010) – The Canadian College of Health Service Executives announced its new name, the Canadian College of Health Leaders during its October 2010 Board of Directors meeting in Halifax. The new name is reflective of who the College is today and its future direction. The College’s commitment to health leaders throughout their career and to Canada’s health system is reflected in the accompanying tagline – Learning, Leading, Inspiring.
For four decades, the Canadian College of Health Leaders has brought together established and emerging health leaders from across Canada to learn, network, and exchange best practices—all with the aim of strengthening Canada’s health system. The College is confident as it enters its next four decades that it is on track to build on, strengthen and renew its services, the new name speaks to the value and benefits of the organization.
“In our consultation with College members as well as potential members it became evident that many did not see themselves reflected in the old name, specifically in the term ‘health service executives’, either because their work was not properly in the health services domain or because they were not in what they perceived as an executive role. The new College name allows us to address this while preparing the College to better recognize the importance of developing leaders early in their career” said College President Ray Racette, MHA, CHE.
“Our new name clearly emphasizes our focus on leadership and learning and our alignment with the recently established LEADS in a Caring Environment leadership capabilities framework. It reflects our commitment to support leadership development across the continuum of a career” commented Board Chair John King, MHA, CHE.
BAD MEDICINE: A Guide to the Real Costs and Consquences of the New Health Care Laws. by Michael D.TANNER
www.cato.org
Can be read online. Single copy $10.
Cato Institute Senior Fellow Michael D. TANNER
Cato Institute,
1000 Massachusetts Ave,N.W.
Washington,D.C. 20001
Can be read online. Single copy $10.
Cato Institute Senior Fellow Michael D. TANNER
Cato Institute,
1000 Massachusetts Ave,N.W.
Washington,D.C. 20001
16.10.10
Safest places to practice medicine in Canada
BEST CITIES PERCENTAGE BELOW THE NATIONAL CRIME SCORE
Caledon, Ont. -70%
Wellington County, Ont. 58
Halton Region, Ont. 58
Lévis, Que. 51
Nottawasaga, Ont. 50
York Region, Ont. 49
Richelieu Saint-Laurent, Que. 48
South Simcoe, Ont. 44
Vaudreuil-Soulange MRC, Que. 44
Blainville, Que. 42
Sources: 2009 and 1999 Crime Severity Index data from the Canadian Centre for Justice Statistics, Maclean’s
Caledon, Ont. -70%
Wellington County, Ont. 58
Halton Region, Ont. 58
Lévis, Que. 51
Nottawasaga, Ont. 50
York Region, Ont. 49
Richelieu Saint-Laurent, Que. 48
South Simcoe, Ont. 44
Vaudreuil-Soulange MRC, Que. 44
Blainville, Que. 42
Sources: 2009 and 1999 Crime Severity Index data from the Canadian Centre for Justice Statistics, Maclean’s
14.10.10
MEDICAL FAME DEPENDS ON PUBLICATION in a WELL-KNOWN LANGUAGE.
LUND- HUNTINGTON'S CHOREA
Progressive and inheritable chorea had been described before 1872, and the most complete clinical description, even including the component of dementia, had been published in Norway by the district physician in Setesdal, Johan Christian LUND as early as in 1859. This report received no international attention and was certainly unknown to Huntington. It was not translated into English until 1959.
A rare disease of the central nervous system characterized by progressive dementia with grimacing, gesticulation, ataxic movements, finger twitching, dysarthria, speech disorders and other bizarre involuntary movements.
On February 15, 1872 George Huntington gave his classic presentation On Chorea at the Meigs and Mason Academy of Medicine, Middleport, Ohio. He was only twenty-two at the time. His lecture was received with acclaim, so he sent his manuscript to the Medical and Surgical Reporter of Philadelphia, where it appeared on 13 April 1872.
An abstract was published in the German literature by Adolf Kussmaul (1822-1902) and Carl Wilhelm Hermann Nothnagel (1841-1905) in 1872 and thereafter the eponym was increasingly used by European authors. Huntington recognised the hereditary nature of the condition, stating in his original paper "When either or both the parents have shown manifestations of the disease, one or more of the offspring invariably suffer from the condition. It never skips a generation to again manifest itself in another. Once having yielded its claims, it never regains them."
Progressive and inheritable chorea had been described before 1872, and the most complete clinical description, even including the component of dementia, had been published in Norway by the district physician in Setesdal, Johan Christian LUND as early as in 1859. This report received no international attention and was certainly unknown to Huntington. It was not translated into English until 1959.
George Huntington born April 9, 1850, East Hampton, Long Island, New York; died March 3, 1916, Cairo, New York.
Huntington's choreaA rare disease of the central nervous system characterized by progressive dementia with grimacing, gesticulation, ataxic movements, finger twitching, dysarthria, speech disorders and other bizarre involuntary movements.
On February 15, 1872 George Huntington gave his classic presentation On Chorea at the Meigs and Mason Academy of Medicine, Middleport, Ohio. He was only twenty-two at the time. His lecture was received with acclaim, so he sent his manuscript to the Medical and Surgical Reporter of Philadelphia, where it appeared on 13 April 1872.
An abstract was published in the German literature by Adolf Kussmaul (1822-1902) and Carl Wilhelm Hermann Nothnagel (1841-1905) in 1872 and thereafter the eponym was increasingly used by European authors. Huntington recognised the hereditary nature of the condition, stating in his original paper "When either or both the parents have shown manifestations of the disease, one or more of the offspring invariably suffer from the condition. It never skips a generation to again manifest itself in another. Once having yielded its claims, it never regains them."
13.10.10
EMIGRATION of TALENT.
After two years in Toronto Dalla Lana School of Public Health Dean Jack MANDEL PhD MPH has moved to Menlo Park, California to become Chief Scientist at EXPONENT.
Dr. Jack S. Mandel has rejoined Exponent as Chief Science Officer. Most recently he was Professor and Director of the Dalla Lana School of Public Health, University of Toronto. From 2002-2008, Dr. Mandel was at Emory University in Atlanta where he served as Rollins Professor and Chair of the Department of Epidemiology, in the Rollins School of Public Health and Deputy Director for Cancer Control and Population Sciences in the Winship Cancer Institute. While at Emory, he was selected as a Georgia Cancer Coalition (GCC) Distinguished Cancer Scholar. From 1999-2002, Dr. Mandel was a Group Vice President at Exponent.
Dr. Mandel was a member of the University of Minnesota faculty from 1975-1999. From 1995 to 1999, he was the Head of the Division of Environmental and Occupational Health in the School of Public Health. In 1996, he received the distinguished honor of being named to the endowed Mayo Chair in Public Health. In 1997, he was the recipient of the Leonard M. Schuman Award for Excellence in Teaching. During his tenure at the University of Minnesota, Dr. Mandel served on a number of international, national, state, and local committees. He has also served as a consultant to industry, professional associations, and governmental agencies.
Dr. Mandel has conducted many case-control, cohort (both prospective and retrospective), cross-sectional, experimental, and methodological studies. He has published more than 200 articles related to epidemiology, including studies of prostate, colorectal, kidney, pancreatic, breast, lung, stomach, hematopoietic and skin cancers. These studies have evaluated a variety of potential etiologic factors including occupational exposures, radiation, pesticides and other chemicals, hormones, medications, diet, alcohol, and tobacco, as well as other lifestyle factors.
Dr. Jack Mandel Joins Exponent as Chief Science Officer
News
September 1, 2010
Dr. Jack S. Mandel has rejoined Exponent as Chief Science Officer. Most recently he was Professor and Director of the Dalla Lana School of Public Health, University of Toronto. From 2002-2008, Dr. Mandel was at Emory University in Atlanta where he served as Rollins Professor and Chair of the Department of Epidemiology, in the Rollins School of Public Health and Deputy Director for Cancer Control and Population Sciences in the Winship Cancer Institute. While at Emory, he was selected as a Georgia Cancer Coalition (GCC) Distinguished Cancer Scholar. From 1999-2002, Dr. Mandel was a Group Vice President at Exponent.
Dr. Mandel was a member of the University of Minnesota faculty from 1975-1999. From 1995 to 1999, he was the Head of the Division of Environmental and Occupational Health in the School of Public Health. In 1996, he received the distinguished honor of being named to the endowed Mayo Chair in Public Health. In 1997, he was the recipient of the Leonard M. Schuman Award for Excellence in Teaching. During his tenure at the University of Minnesota, Dr. Mandel served on a number of international, national, state, and local committees. He has also served as a consultant to industry, professional associations, and governmental agencies.
Dr. Mandel has conducted many case-control, cohort (both prospective and retrospective), cross-sectional, experimental, and methodological studies. He has published more than 200 articles related to epidemiology, including studies of prostate, colorectal, kidney, pancreatic, breast, lung, stomach, hematopoietic and skin cancers. These studies have evaluated a variety of potential etiologic factors including occupational exposures, radiation, pesticides and other chemicals, hormones, medications, diet, alcohol, and tobacco, as well as other lifestyle factors.
Subscribe to:
Posts (Atom)